Researchers from UND School of Medicine and Mayo Clinic have conducted a clinical trial to determine whether using a multispecies probiotic could diminish the symptoms of irritable bowel syndrome (IBS). The researchers evaluated 25 patients with IBS as defined by Rome III criteria over a period of 60 days. Patients were treated with a multispecies [...]


















